HEALTH

Clarion Brands adds probiotic Florajen to product lineup
TREVOSE, Pa. - Clarion Brands, a portfolio company of Swander Pace Capital, on Tuesday announced the acquisition of the probiotic brand Florajen.

“Florajen is the perfect addition to our portfolio,” stated Gary Downing, CEO of Clarion Brands. “We have a longstanding history of partnering with healthcare professionals to provide consumers with trusted solutions to their everyday health needs, and Florajen represents both an exciting and strategic next step for us.”
88 Health Products addresses fructose malabsorption with FructosAid
ANN ARBOR, Mich. - 88 Health Products on Monday introduced FructosAid brand xylose isomerase to address fructose malabsorption. The supplement is available through Swanson Health Products and on Amazon.com.

Previously known as dietary fructose intolerance, fructose malabsorption is a digestive complication that can result in abdominal pain, bloating, gas and diarrhea. While experts suggest that up to one third of the general population may be affected, fructose malabsorption remains an under-recognized health challenge with few over-the-counter solutions.

Perrigo launches store brand equivalent for Zegerid OTC

DUBLIN - Perrigo announced Monday that the U.S. Food and Drug Administration has approved the company's ANDA for omeprazole and sodium bicarbonate capsules, 20mg/1100mg. This approval will initiate the first store brand launch of an equivalent product to Zegerid OTC capsules.

Shipments to retail customers have already commenced.

Zegerid OTC is indicated for the treatment of frequent heartburn. National brand sales for the twelve months ending June 2016 were $27 million.
Kline: Growth across 'natural OTCs' outpacing overall OTC growth

PARSIPPANY, N.J. – More and more consumers are in search of "natural" solutions to their ailments, including both homeopathic remedies and supplements supportive of a healthier lifestyle, Kline Market Research noted in its latest study, Natural OTCs: Impact of non-drug products on the U.S. OTC market, which was released Monday.
GMDC and J&J showcase diabetes opportunity in latest infocast

COLORADO SPRINGS, Colo. - GMDC on Thursday hosted Sally Manoufar, senior manager Health & Wellness at Johnson & Johnson, and Sara Bender, senior channel marketing manager at Johnson & Johnson, to learn about Johnson & Johnson's diabetes front-end solution as part of the group's lunchtime Infocast Event.
Bayer brings Aleve Direct Therapy to TENS device space

WHIPPANY, N.J. - Bayer on Thursday joined the number of companies fielding a TENS pain relief device with Aleve Direct Therapy.

"For people suffering from lower back pain the availability of the Aleve Direct Therapy TENS Device is good news. The device provides drug-free, deep penetrating lower-back pain relief, without a prescription," stated Fred Duchin, VP marketing Analgesics of Bayer's Cough & Cold, Cardiovascular, Consumer Health Division.
Omron releases open API, invites mobile app developers to collaborate

LAKE FOREST, Ill. - Omron Healthcare on Thursday announced the release of the Omron Application Program Interface and invited mobile app developers to participate in open-source collaboration.
British journal argues against prenatal multis, CRN counters

LONDON - Prenatal multivitamins are an "unnecessary expense" according to a review published by BMJ earlier this week, which advised pregnant women to focus on supplementing with folic acid and vitamin D supplements while improving their overall diet.
NCPA posts dates for revenue-boosting, front-end seminar, including at ABC's ThoughtSpot 2016

ALEXANDRIA, Va. - The National Community Pharmacists Association on Tuesday announced its 2016 lineup of one-day seminars to help community pharmacy owners and front-end staff hone their merchandising and marketing skills, as well as a new sponsorship by Good Neighbor Pharmacy and AmerisourceBergen Drug Corporation to continue the Front-End Profit Building Seminars program.
FDA approves OTC availability of PeriCoach, an at-home pelvic floor trainer device

DENVER - Analytica on Wednesday announced that the U.S. Food and Drug Administration has approved the PeriCoach at-home pelvic floor trainer device and smartphone app as an over-the-counter treatment for mild, moderate and stress urinary incontinence and urge incontinence.

Pelvic floor muscle exercise is recommended as first line non-pharmacologic treatment for the millions of women – estimated at one in three – who suffer from urinary incontinence.

A strong pelvic floor is also associated with improved sexual function and satisfaction.